STATE-OF-THE-ART PAPER
When Children With Kawasaki Disease Grow UpMyocardial and Vascular Complications in Adulthood
John B. Gordon, MD*,*,
Andrew M. Kahn, MD, PhD and
Jane C. Burns, MD
* San Diego Cardiac Center, San Diego, California
Department of Medicine, University of California San Diego School of Medicine and Rady Children's Hospital, San Diego, California
Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital, San Diego, California
Manuscript received August 25, 2008;
revised manuscript received March 25, 2009,
accepted April 17, 2009.
* Reprint requests and correspondence: Dr. John B. Gordon, San Diego Cardiac Center, 3131 Berger Street, Suite 200, San Diego, California 92123 (Email: AdultKD{at}gmail.com).
Kawasaki disease (KD) is an acute, self-limited vasculitis that typically occurs in young children and was first described by Japanese pediatrician Tomisaku Kawasaki in 1967. Although originally thought to be a rare condition, KD has become the most common cause of acquired heart disease in the pediatric age group in developed countries. The majority of patients with KD appear to have a benign prognosis, but a subset of patients with coronary artery aneurysms are at risk for ischemic events and require lifelong treatment. In the 4 decades that have passed since the initial recognition of KD, the number of patients reaching adulthood has continued to grow. Adult cardiologists will be increasingly involved in the management of these patients. Currently, there are no established guidelines for the evaluation and treatment of adult patients who have had KD. We review here the current literature that may be helpful to clinicians who care for adults who experienced KD in childhood.
Key Words: aneurysm vasculitis myocardial infarction myocardial flow reserve myocarditis
|
Abbreviations and Acronyms
| | AHA = American Heart Association | | CT = computed tomography | | IMT = intimal medial thickness | | IVIG = intravenous immunoglobulin | | KD = Kawasaki disease | | LOE = Level of Evidence | | MR = magnetic resonance | | SMR = standardized mortality ratio |
|
Related Articles
-
Not Just Coronary Arteritis, Kawasaki Disease Is a Myocarditis, Too
- Nagib Dahdah
J. Am. Coll. Cardiol. 2010 55: 1507.
[Full Text]
[PDF]
-
Reply
- Welton M. Gersony
J. Am. Coll. Cardiol. 2010 55: 1507-1508.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
C. Shimizu, S. Jain, S. Davila, M. L. Hibberd, K. O. Lin, D. Molkara, J. R. Frazer, S. Sun, A. L. Baker, J. W. Newburger, et al.
Transforming Growth Factor-{beta} Signaling Pathway in Patients With Kawasaki Disease
Circ Cardiovasc Genet,
February 1, 2011;
4(1):
16 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. F. Printz, L. A. Sleeper, J. W. Newburger, L. L. Minich, T. Bradley, M. S. Cohen, D. Frank, J. S. Li, R. Margossian, G. Shirali, et al.
Noncoronary Cardiac Abnormalities Are Associated With Coronary Artery Dilation and With Laboratory Inflammatory Markers in Acute Kawasaki Disease
J. Am. Coll. Cardiol.,
January 4, 2011;
57(1):
86 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Dahdah
Not Just Coronary Arteritis, Kawasaki Disease Is a Myocarditis, Too
J. Am. Coll. Cardiol.,
April 6, 2010;
55(14):
1507 - 1507.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Gordon, A. M. Kahn, and J. C. Burns
Reply.
J. Am. Coll. Cardiol.,
April 6, 2010;
55(14):
1508 - 1508.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Gersony
The Adult After Kawasaki Disease: The Risks for Late Coronary Events
J. Am. Coll. Cardiol.,
November 17, 2009;
54(21):
1921 - 1923.
[Full Text]
[PDF]
|
 |
|
|